Previous studies have shown that CIH can induce dyslipidemia and atherosclerosis in ApoE−/− mice [12] by inhibiting the expression and activity of LPL and affecting the expression of Angptl4, a potential inhibitor of LPL in adipose tissue but not in heart tissue [13–15]. The gene discussed is ANGPTL4; the disease is metabolic syndrome.